CA2306772A1 - Utilisation d'alcools aliphatiques c18 a c26 pour preparer un medicament destine a traiter les dermatites hyperproliferantes - Google Patents

Utilisation d'alcools aliphatiques c18 a c26 pour preparer un medicament destine a traiter les dermatites hyperproliferantes Download PDF

Info

Publication number
CA2306772A1
CA2306772A1 CA002306772A CA2306772A CA2306772A1 CA 2306772 A1 CA2306772 A1 CA 2306772A1 CA 002306772 A CA002306772 A CA 002306772A CA 2306772 A CA2306772 A CA 2306772A CA 2306772 A1 CA2306772 A1 CA 2306772A1
Authority
CA
Canada
Prior art keywords
medicament
manufacture
treatment
aliphatic alcohols
skin disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002306772A
Other languages
English (en)
Other versions
CA2306772C (fr
Inventor
Laura Pope
Mohammed H. Khalil
John F. Marcelletti
Lee R. Katz
David H. Katz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Avanir Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2306772A1 publication Critical patent/CA2306772A1/fr
Application granted granted Critical
Publication of CA2306772C publication Critical patent/CA2306772C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/342—Alcohols having more than seven atoms in an unbroken chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention porte sur un procédé de traitement des dermatites hyparproliférantes bénignes ou malignes qui consiste à appliquer sur les lésions cutanées un alcool aliphatique C18 à C26 dans un excipient pharmacocompatible.
CA002306772A 1996-12-17 1997-12-05 Utilisation d'alcools aliphatiques c18 a c26 pour preparer un medicament destine a traiter les dermatites hyperproliferantes Expired - Lifetime CA2306772C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US76772296A 1996-12-17 1996-12-17
US08/767,722 1996-12-17
PCT/US1997/022945 WO1998026771A1 (fr) 1996-12-17 1997-12-05 Utilisation d'alcools aliphatiques c18 a c26 pour preparer un medicament destine a traiter les dermatites hyperproliferantes

Publications (2)

Publication Number Publication Date
CA2306772A1 true CA2306772A1 (fr) 1998-06-25
CA2306772C CA2306772C (fr) 2004-10-12

Family

ID=25080353

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002306772A Expired - Lifetime CA2306772C (fr) 1996-12-17 1997-12-05 Utilisation d'alcools aliphatiques c18 a c26 pour preparer un medicament destine a traiter les dermatites hyperproliferantes

Country Status (4)

Country Link
EP (1) EP1039885A1 (fr)
AU (1) AU7735298A (fr)
CA (1) CA2306772C (fr)
WO (1) WO1998026771A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6630168B1 (en) 1997-02-20 2003-10-07 Biomedicines, Inc. Gel delivery vehicles for anticellular proliferative agents
EP1436006A4 (fr) * 2001-10-16 2006-06-07 Avanir Pharmaceuticals Inhibition virale par n-docosanol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2614531A1 (fr) * 1987-04-29 1988-11-04 Martel Patrick Composition emolliente pour ongles
ATE399004T1 (de) * 1993-12-13 2008-07-15 Avanir Pharmaceuticals Formulierungen aus c-20 bis c-28 alkoholen und saccharoseestern

Also Published As

Publication number Publication date
EP1039885A1 (fr) 2000-10-04
CA2306772C (fr) 2004-10-12
AU7735298A (en) 1998-07-15
WO1998026771A1 (fr) 1998-06-25

Similar Documents

Publication Publication Date Title
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
WO1996012498A3 (fr) Compositions dermatologiques contenant du peroxyde de benzoyle et compose reduisant l'irritation de la peau
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
AU3632497A (en) Use of the chelating agent clioquinol for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease
AU6915396A (en) Multiple sclerosis treatment
WO1998010767A3 (fr) Utilisation de derives de la quinazoline pour la fabrication d'un medicament destine au traitement de troubles cutanes hyperproliferatifs
CA2181742A1 (fr) Reduction de l'irritation de la peau pendant l'administration de medicament par electrotransport
CA2373794A1 (fr) Compositions et utilisation d'et743 pour le traitement du cancer
PL323798A1 (en) Application of derivatives of vitamin d4 in treating skin diseases
EP0396184A3 (fr) Utilisation du kétoconazole et un rétinoide pour le traitement de l acné vulgaire
AU3459689A (en) Treatment of skin disorders
WO2001024783A3 (fr) Utilisation de (+)-tramadol, de o-demethyltramadol ou de (+)-o-demethyltramadol, de o-desmethyle-n-mono-desmethyl-tramadol ou de (+)o-desmethyl-n-mono-desmethyl-tramadol pour traiter l'incontinence urinaire
CA2200480A1 (fr) Nouvelle utilisation de prostaglandines
AU6924698A (en) Use of at least an irvingia gabonensis extract in a cosmetic and/or pharmaceutical product
MY114716A (en) Prophylactic and/or therapeutic treatment of dyspeptic symptoms
SE9300971D0 (sv) Hudvaardskomposition
WO2000008007A3 (fr) Derives de cyclopentabenzofuranne et leur utilisation
PL348781A1 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
EP1561462A3 (fr) Compositions pour traiter l'arythmie et procédés de traitement
CA2306772A1 (fr) Utilisation d'alcools aliphatiques c18 a c26 pour preparer un medicament destine a traiter les dermatites hyperproliferantes
CZ223199A3 (cs) Použití inhibitorů COMT nebo jejich farmaceuticky vhodných solí nebo esterů pro výrobu léčiva k prevenci diabetických vaskulárních dysfunkcí
NZ268039A (en) Use of efaroxan in treating parkinson's disease
CA2126704A1 (fr) Compositions dermatologiques et methodes de traitement de la peau
CA2115045A1 (fr) Composition pour la guerison des dermopathies proliferatives

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20171205

MKEX Expiry

Effective date: 20171205